Q2 2022 EARNINGS CALL

PRESENTATION.

SEVENUM, 03 AUGUST 2022

2

Q2 2022

EARNINGS CALL

LIVE FROM OUR HEADQUARTERS IN SEVENUM.

STEFAN FELTENS, CEO.

JASPER EENHORST, CFO.

3

TODAY'S AGENDA.

FINANCIAL

PERFORMANCE.

UPDATE ON BUSINESS

AND STRATEGY.

OUTLOOK

AND GUIDANCE.

4

FINANCIAL PERFORMANCE.

HIGHLIGHTS H1 2022.

5

  • FY TOP AND BOTTOM-LINE GUIDANCE CONFIRMED.

H1 SALES UP 11% (15% in Q2 AFTER 7% in Q1). NON-RX GREW BY 16% IN H1 (Q2 18%). ADJ. EBITDA MARGIN FOR ONGOING BUSINESS AT -1.5%.

  • POSITIVE OPERATING CASH FLOW AT EUR 15M IN H1.

CONTINUED FAVOURABLE WORKING CAPITAL MOVEMENTS.

  • SUSTAINED STRONG CUSTOMER GROWTH AND RECORD

CUSTOMER SATISFACTION.

NPS OF 74 IN Q2, DRIVEN BY FURTHER IMPROVEMENTS IN OUR CUSTOMER PROPOSITION. ACTIVE CUSTOMER BASE 8.6M: UP 0.8M IN H1 AND 1.5M YOY.

  • ITALIAN EXPANSION FULLY ON TRACK.

NEW DISTRIBUTION CENTRE IN MILAN OPERATIONAL SINCE 1 AUG.

  • E-RXLAUNCH IN FIRST TWO GERMAN REGIONS AHEAD.

30,000 E-SCRIPTS SUCCESSFULLY PASSED BY JULY. SINCE THEN, ACCELERATION WITH MORE THAN 100,000 E-SCRIPTS DISPENSED.

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Shop Apotheke Europe NV published this content on 03 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2022 10:37:12 UTC.